About the Valve Research Group
Our group was founded in 1995 initially as a research clinic to understand more about the origin of symptoms in patients with heart valve disease. It rapid expanded over the next few years to become an organisation interested in evaluating the durability and performance of prosthetic heart valves and develop new techniques for symptom assessment.
In recent years the size of the group has grown substantially to include interventional structural interventional cardiologists, consultant imaging cardiologists, cardiac surgeons, bioengineers, computational modelers, specialist heart valve nurses, highly specialist physiologists and a spectrum of PhD students. We now have translational research interests than span the breadth of heart valve disease.
The department is strong in cardiac imaging with specialists in all relevant fields, echocardiography, magnetic resonance, computerised tomography and nuclear medicine. This has allowed an expansion in training opportunities for registrars and external national and international fellows.
The echocardiography staff have formal British Society of Echocardiography, European or equivalent US or Australian accreditation. The Department is British Society of Echocardiography accredited and was recently reaccredited. Quality control is embedded within our processes. All studies performed by trainee registrars or sonographers are checked by a senior sonographer.Meet the whole staff
The main research themes are
- Optimising the care of heart valve patients with specialist multidisciplinary valve clinic models.
- Investigating the natural history of native and prosthetic heart valve disease.
- Developing new imaging biomarkers for the early detection of heart valve symptoms.
- Optimising the care of patients with infective endocarditis with “Endocarditis Team models”
- Improving outcomes following heart valve disease surgery.
- Developing new imaging techniques with cardiac magnetic resonance imaging, cardiac computed tomography and bioengineering.
- Simulation of patient outcomes using advanced computational techniques.
- Developing in collaboration with industry minimally invasive transcathter heart valve therapies to treat valvular heart disease (transcathter aortic/mitral and tricuspid valve replacement).
- Predicting patient outcomes following novel procedures.
Join our studies
Alongside our clinical and research interests, the group has an active interest in teaching and training in cardiac imaging, research methodology and heart valve disease.
Our mission statement is to improve the knowledge, understanding and outcome of patients with heart valve disease and to improve treatment outcomes.
We hope you find the content on our website useful.
Please check back again soon for new uploaded material.Get in contact Support us